Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN NOS for Familial hypertriglyceridaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where INSULIN NOS was used for Familial hypertriglyceridaemia.

Most Reported Side Effects for INSULIN NOS

Side Effect Reports % Deaths Hosp.
Foetal exposure during pregnancy 764 12.5% 28 149
Drug ineffective 608 10.0% 122 315
Hypoglycaemia 568 9.3% 69 358
Premature baby 524 8.6% 11 104
Maternal exposure during pregnancy 484 7.9% 8 105
Completed suicide 413 6.8% 413 153
Exposure during pregnancy 403 6.6% 3 96
Off label use 385 6.3% 69 163
Toxicity to various agents 382 6.3% 242 237
Premature delivery 353 5.8% 3 45
Blood glucose increased 275 4.5% 5 105
Hypotension 248 4.1% 88 186
Acute kidney injury 225 3.7% 63 186
Condition aggravated 209 3.4% 38 105
Hyperglycaemia 205 3.4% 25 119

Other Indications for INSULIN NOS

Product used for unknown indication (2,187) Diabetes mellitus (872) Type 2 diabetes mellitus (774) Gestational diabetes (293) Type 1 diabetes mellitus (268) Foetal exposure during pregnancy (160) Toxicity to various agents (99) Hyperglycaemia (87) Hyperkalaemia (84) Diabetic ketoacidosis (57)

Other Drugs Used for Familial hypertriglyceridaemia

OLEZARSEN (33) GEMFIBROZIL (15) FENOFIBRATE (11) LOMITAPIDE (11) OMEGA-3-ACID ETHYL ESTERS (7) EVOLOCUMAB (5)

Related Pages

INSULIN NOS Full Profile All Familial hypertriglyceridaemia Drugs INSULIN NOS Demographics INSULIN NOS Timeline